Clinical trial · Observational
Vitamin D Levels And Myoma Uteri
Vitamin D Levels İn Women With and Without Myoma Uteri
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Women with at least one uterine leiomyoma and polycystic ovary syndrome over 10 mm and women with normal ultrasonographic findings were included in the study. Blood samples were taken for biochemical analysis such as vitamin D, calcium, magnesium, phosphorus, thyroid stimulating hormone (TSH), hemoglobin (hb), hematocrit (htc), platelet (plt), and albumin. The study groups were compared in terms of these biochemical markers and family history of patients, daily sunshine hours, clothing preferences and education level.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Myoma;Uterus | — | UNRESOLVED | — |
| Polycystic Ovary | — | UNRESOLVED | — |
| Vitamin D Deficiency | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- study group
- description
- In Woman With Myoma Uteri
- label
- control group
- description
- In Woman Without Myoma Uteri
Primary outcomes (1)
- measure
- Vitamin D levels
- timeFrame
- december 2018- march 2019
- description
- Vitamin D levels in blood test
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
- Maximum age
- 50 Years
Show eligibility criteria text
Inclusion Criteria: The reproductive age women (25-50 years) with at least one 10 mm or larger diameter leiomyoma detected by transvaginal ultrasound were the study group. Exclusion Criteria: * Patients with a history of myomectomy, * chronic systemic disease * malignancy * history of adenomyosis * women in menopause * pregnant women * vitamin D supplementation * lactation * abortion and pregnancy loss in the last 6 months * oral contraceptive / hormonal agents in the last 3 months
References
Publications (0)
Data not yet available